dc.contributor.author | Koksal M. | |
dc.contributor.author | Ozkan I. | |
dc.contributor.author | Yarim M. | |
dc.contributor.author | Sirri Bilge S. | |
dc.contributor.author | Bozkurp A. | |
dc.contributor.author | Erol D.D. | |
dc.date.accessioned | 2020-06-21T09:37:15Z | |
dc.date.available | 2020-06-21T09:37:15Z | |
dc.date.issued | 2011 | |
dc.identifier.issn | 0034-7752 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12712/4703 | |
dc.description.abstract | In this study, synthesis of a series of3,6-diaryl-l,2,4-triazoIo[3,4-b]-1, 3,4-thiadiazines by the condensation of appropriate 5-(3,4-dichlorophenyl)-2- (aroylmethyl)thio-1,3,4-oxadiazoles and hydrazine hydrate in acetic acid is described. The structures of newly synthesized compounds were confirmed by IR, 'H-NMR and elemental analysis. All the compounds were evaluated for anti-inflammatory activity by determining their ability to provide protection against carrageenan-induced edema in rat paw. In addition, ulcerogenic activities of the compounds were determined. The anti-inflammatory data scoring showed that most of the compounds exhibited anti-inflamatory activity profile at 100 mg/kg. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | SYSCOM 18 S.R.L. | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Anti-inflammatory activity | en_US |
dc.subject | NSAIDs | en_US |
dc.subject | Synthesis | en_US |
dc.subject | Triazolo-1,3,4-thiadiazines | en_US |
dc.title | Studies on synthesis and anti-inflammatory activities of novel 1,2,4-triazolo [3,4-b] -1,3,4-thiadiazines | en_US |
dc.type | article | en_US |
dc.contributor.department | OMÜ | en_US |
dc.identifier.volume | 62 | en_US |
dc.identifier.issue | 11 | en_US |
dc.identifier.startpage | 1069 | en_US |
dc.identifier.endpage | 1072 | en_US |
dc.relation.journal | Revista de Chimie | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |